Racial and ethnic inequities are pervasive in clinical research—from the systemic factors that deter underrepresented populations from pursuing careers in science and medicine, to the discrimination, lack of support, and other hardships faced by those who do enter the biomedical profession.
Fifty years ago, the National Cancer Act was signed into law, providing the National Cancer Institute with new authority to expand discoveries in basic, clinical, and translational science, which included building a nationwide network of cancer centers to treat thousands of patients each day.
As we head into the third year of the global COVID-19 pandemic, everyone would just like it to be over.
The easiest way to respond to the ethics of doctors, nurses, and health care in the Third Reich is to dismiss what happened as the product of fringe practitioners getting permission from, or being forced by, fanatical ideological leaders to undertake manifestly bad science upon hated minorities.
Emergent public-private partnerships (PPPs) have risen to the occasion to streamline and coordinate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. With these monumental efforts have come important public discussions about equitable access and representation in clinical trials (CTs).
In mid-October, First Lady Dr. Jill Biden asked to visit the Hollings Cancer Center at the Medical University of South Carolina to help raise awareness of the need for breast cancer screening, education, and treatment—particularly among underserved minority women.
Spanning part of September and October, it is a time to celebrate and recognize Hispanics or Latinos or Latinx persons* for their contributions. This nationwide observation begins on Sept. 15 when several countries in Latin America celebrate independence—Costa Rica, El Salvador, Guatemala, Honduras, and Nicaragua. Mexico celebrates independence on Sept. 16 and Chile on Sept. 18. Towards the end of Hispanic Heritage Month, Oct. 12 is also recognized as DÃa de la Raza.1 Persons of Hispanic ancestry have walked the Americas since 1492.
There is reason for concern about fascism rising in the United States. The reason is primarily Trumpism, followed by racism, followed by right-wing seditionist impulses.
While I’m glad that in a recent response to questions from a congressional committee NIH recognizes that sexual harassment is a major obstacle in the advancement of science and has put new processes in place to address this issue, the letter does not adequately address the lack of response in the case of Dr. Grothey.
In early 2020, telehealth was a hot new trend in patient care, but with utilization sporadic and episodic at best, providers were generally skeptical as to whether this virtual technique of delivering care was a viable option for advanced clinical services, especially in oncology.
